Format
Sort by
Items per page

Send to

Choose Destination

Search results

Items: 1 to 20 of 47

1.

Screening for subclinical subclavian artery stenosis before coronary artery bypass grafting: Should we do it?

Abdul Jabbar A, Houston J, Burket M, Il'Giovine ZJ, Srivastava BK, Agarwal A.

Echocardiography. 2017 Apr 12. doi: 10.1111/echo.13528. [Epub ahead of print] Review.

PMID:
28401711
2.

Placentation in watersnakes I: Placental histology and development in North American Nerodia (Colubridae: Natricinae).

Blackburn DG, Anderson KE, Aronson KW, Burket MK, Chin JF, San-Francisco SK, Callard IP.

J Morphol. 2017 May;278(5):665-674. doi: 10.1002/jmor.20663. Epub 2017 Feb 1.

PMID:
28145572
3.

Twelve-Month Results of the Nitinol Astron Stent in Iliac Artery Lesions.

Burket MW, Brodmann M, Metzger C, Tan K, Jaff MR.

J Vasc Interv Radiol. 2016 Nov;27(11):1650-1656.e1. doi: 10.1016/j.jvir.2016.06.008. Epub 2016 Aug 16.

PMID:
27542591
4.

Drug-Eluting Stents Are the Default Strategy for Superficial Femoral Artery Intervention Now.

Burket MW.

Circulation. 2016 Jan 19;133(3):320-9; discussion 329. doi: 10.1161/CIRCULATIONAHA.115.018034. Review. No abstract available.

5.

Trial of a Paclitaxel-Coated Balloon for Femoropopliteal Artery Disease.

Rosenfield K, Jaff MR, White CJ, Rocha-Singh K, Mena-Hurtado C, Metzger DC, Brodmann M, Pilger E, Zeller T, Krishnan P, Gammon R, Müller-Hülsbeck S, Nehler MR, Benenati JF, Scheinert D; LEVANT 2 Investigators..

N Engl J Med. 2015 Jul 9;373(2):145-53. doi: 10.1056/NEJMoa1406235. Epub 2015 Jun 24.

6.

Paclitaxel-eluting stents for the treatment of femoropopliteal arterial stenoses: focus on the Zilver PTX drug-eluting peripheral stent.

Moukarbel GV, Burket MW.

Expert Rev Med Devices. 2015 Mar;12(2):157-62. doi: 10.1586/17434440.2015.985653. Epub 2014 Nov 24. Review.

PMID:
25418344
7.

Stenting and medical therapy for atherosclerotic renal-artery stenosis.

Cooper CJ, Murphy TP, Cutlip DE, Jamerson K, Henrich W, Reid DM, Cohen DJ, Matsumoto AH, Steffes M, Jaff MR, Prince MR, Lewis EF, Tuttle KR, Shapiro JI, Rundback JH, Massaro JM, D'Agostino RB Sr, Dworkin LD; CORAL Investigators..

N Engl J Med. 2014 Jan 2;370(1):13-22. doi: 10.1056/NEJMoa1310753. Epub 2013 Nov 18.

8.

Strategies for multivessel revascularization in patients with diabetes.

Farkouh ME, Domanski M, Sleeper LA, Siami FS, Dangas G, Mack M, Yang M, Cohen DJ, Rosenberg Y, Solomon SD, Desai AS, Gersh BJ, Magnuson EA, Lansky A, Boineau R, Weinberger J, Ramanathan K, Sousa JE, Rankin J, Bhargava B, Buse J, Hueb W, Smith CR, Muratov V, Bansilal S, King S 3rd, Bertrand M, Fuster V; FREEDOM Trial Investigators..

N Engl J Med. 2012 Dec 20;367(25):2375-84. doi: 10.1056/NEJMoa1211585. Epub 2012 Nov 4.

9.

Percutaneous coronary intervention through unintentional sheath placement in the inferior epigastric artery.

Moza A, Taleb M, Cooper CJ, Burket MW.

Cardiovasc Interv Ther. 2013 Jan;28(1):98-100. doi: 10.1007/s12928-012-0121-4. Epub 2012 Aug 9.

PMID:
22875748
10.

Paclitaxel-eluting stents show superiority to balloon angioplasty and bare metal stents in femoropopliteal disease: twelve-month Zilver PTX randomized study results.

Dake MD, Ansel GM, Jaff MR, Ohki T, Saxon RR, Smouse HB, Zeller T, Roubin GS, Burket MW, Khatib Y, Snyder SA, Ragheb AO, White JK, Machan LS; Zilver PTX Investigators..

Circ Cardiovasc Interv. 2011 Oct 1;4(5):495-504. doi: 10.1161/CIRCINTERVENTIONS.111.962324. Epub 2011 Sep 27.

11.

Platelet activation in patients with atherosclerotic renal artery stenosis undergoing stent revascularization.

Haller S, Adlakha S, Reed G, Brewster P, Kennedy D, Burket MW, Colyer W, Yu H, Zhang D, Shapiro JI, Cooper CJ.

Clin J Am Soc Nephrol. 2011 Sep;6(9):2185-91. doi: 10.2215/CJN.03140411. Epub 2011 Aug 4.

12.

A role for embolic protection in the management of acute limb ischemia.

Taleb M, Burket MW, Cooper CJ.

Tech Vasc Interv Radiol. 2011 Jun;14(2):75-9. doi: 10.1053/j.tvir.2011.01.004. Review.

PMID:
21550509
13.

Stent fracture in the coronary and peripheral arteries.

Adlakha S, Sheikh M, Wu J, Burket MW, Pandya U, Colyer W, Eltahawy E, Cooper CJ.

J Interv Cardiol. 2010 Aug;23(4):411-9. Review.

PMID:
20806458
14.

Predictors of embolization during protected renal artery angioplasty and stenting: Role of antiplatelet therapy.

Kanjwal K, Cooper CJ, Virmani R, Haller S, Shapiro JI, Burket MW, Steffes M, Brewster P, Zhang H, Colyer WR Jr.

Catheter Cardiovasc Interv. 2010 Jul 1;76(1):16-23. doi: 10.1002/ccd.22469.

PMID:
20209644
15.

A security blanket for the superior vena cava.

Burket MW.

Catheter Cardiovasc Interv. 2009 Dec 1;74(7):1089. doi: 10.1002/ccd.22338. No abstract available.

PMID:
19953520
16.

Passing sheaths and electrode catheters through inferior vena cava filters: safer than we think?

Kanjwal Y, John JM, Burket MW.

Catheter Cardiovasc Interv. 2009 Nov 15;74(6):966-9. doi: 10.1002/ccd.22171.

PMID:
19642198
17.

Percutaneous intervention for chronic total occlusion of the internal iliac artery for unrelenting buttock claudication.

Adlakha S, Burket M, Cooper C.

Catheter Cardiovasc Interv. 2009 Aug 1;74(2):257-9. doi: 10.1002/ccd.21966.

PMID:
19213070
18.

Complete versus partial distal embolic protection during renal artery stenting.

Kanjwal K, Haller S, Steffes M, Virmani R, Shapiro JI, Burket MW, Cooper CJ, Colyer WR Jr.

Catheter Cardiovasc Interv. 2009 May 1;73(6):725-30. doi: 10.1002/ccd.21932. Erratum in: Catheter Cardiovasc Interv. 2009 Aug 1;74(2):375.

PMID:
19198007
19.

What works for cars works for carotids: The value of hybrids.

Burket MW.

Catheter Cardiovasc Interv. 2008 Dec 1;72(7):1008. doi: 10.1002/ccd.21874. No abstract available.

PMID:
19021277
20.

Radiation-induced peripheral artery disease.

Jurado JA, Bashir R, Burket MW.

Catheter Cardiovasc Interv. 2008 Oct 1;72(4):563-8. doi: 10.1002/ccd.21681. Review.

PMID:
18819153

Supplemental Content

Loading ...
Support Center